Related references
Note: Only part of the references are listed.
Review
Microbiology
Jake G. Natalini et al.
Summary: New methods and technologies have revealed that the human lungs are not sterile, but have a distinct lung microbiome with low biomass and dynamic microbial immigration. Understanding the microbial ecology of the lung is crucial for identifying new therapeutic targets and improving lung health.
NATURE REVIEWS MICROBIOLOGY
(2023)
Review
Cell Biology
Chunyi Li et al.
Summary: Recent advances have revealed the existence of a bidirectional communication between the central nervous system and the lung, known as the brain-lung axis. This axis is involved in regulating physiological states and is associated with various disease states, providing an important target for treatment strategies.
CELLULAR AND MOLECULAR NEUROBIOLOGY
(2023)
Review
Neurosciences
Ashley N. Brandebura et al.
Summary: There is increasing evidence that astrocytes play a significant role in neurodegenerative disorders, both as initiators and contributors to disease progression. This review discusses the involvement of astrocytes in disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, and explores their importance in supporting neuronal function in the healthy brain as well as the changes they undergo in pathological conditions.
NATURE REVIEWS NEUROSCIENCE
(2023)
Article
Virology
Ali A. Asadi-Pooya et al.
Summary: This large population-based study shows that chronic post-COVID brain fog has significant associations with sex (female), respiratory symptoms at the onset, and the illness severity (ICU admission).
JOURNAL OF MEDICAL VIROLOGY
(2022)
Article
Multidisciplinary Sciences
Zoeb Jiwaji et al.
Summary: Alzheimer's disease affects astrocytes, and both A beta and Tau pathology induce changes in astrocytes. A beta mainly influences the expression of AD risk genes, while both pathologies induce age-dependent changes and have overlapping features with astrocytes found in post-mortem AD patients. Both A beta and Tau pathology alter the characteristics of astrocytes, including repression of bioenergetic and translation machinery, induction of inflammation pathways, and expression of protein degradation/proteostasis genes. Astrocyte-specific expression of Nrf2, a protective factor, can recapitulate elements of these astrocyte changes and reduce A beta deposition and phospho-tau accumulation. This Nrf2 expression also improves brain-wide transcriptional deregulation, cellular pathology, neurodegeneration, and behavioral/cognitive deficits.
NATURE COMMUNICATIONS
(2022)
Review
Microbiology
Ousman Bajinka et al.
Summary: The appreciation of human microbiome is gaining strong grounds in biomedical research, focusing on the lung-brain axis in addition to the gut-brain axis. Interdisciplinary approaches based on emerging studies are recommended to develop effective treatments for lung induced neurodegenerative diseases. In-depth understanding of the bi-directional communication between host and microbiome in the lung could confer treatment to respiratory infections, alleviate stress, anxiety, and enhance neurological effects.
CRITICAL REVIEWS IN MICROBIOLOGY
(2022)
Article
Multidisciplinary Sciences
Leon Hosang et al.
Summary: The lung microbiota plays an important role in regulating the immune reactivity of the central nervous system and influencing the susceptibility to autoimmune disease development.
Article
Multidisciplinary Sciences
Gwenaelle Douaud et al.
Summary: Through long-term observation of participants' MRI images, it was found that COVID-19 infection is associated with abnormal brain changes, including a reduction in gray matter thickness in the orbitofrontal cortex and parahippocampal gyrus, greater changes in markers of tissue damage in regions functionally connected to the primary olfactory cortex, and a greater reduction in global brain size. Infected individuals also showed significant cognitive decline.
Article
Biochemistry & Molecular Biology
Ziyad Al-Aly et al.
Summary: This study analyzed the US Department of Veterans Affairs national healthcare databases to investigate the occurrence of Long COVID and death risk after breakthrough SARS-CoV-2 infection. The findings showed that vaccination significantly reduced the risk of death and post-acute sequelae but did not eliminate them completely. These results underscore the importance of further research on prevention and post-acute care for breakthrough infections.
Article
Multidisciplinary Sciences
Gi Uk Jeong et al.
Summary: This study demonstrates that SARS-CoV-2 can infect the eyes and cause retinal inflammation in transgenic mice and Syrian hamster models. The virus can also spread from the lungs to the brain and eyes through neuronal pathways. These findings contribute to a better understanding of viral transmission and clinical characteristics of SARS-CoV-2 and can aid in improving COVID-19 control procedures.
NATURE COMMUNICATIONS
(2022)
Article
Multidisciplinary Sciences
Manina M. Etter et al.
Summary: Growing evidence suggests the association between COVID-19 and acute and long-term neurological dysfunction. This study found that severe Neuro-COVID is characterized by blood-brain barrier impairment, elevated microglia activation markers, and immune response targeting self-antigens and non-self-antigens. Post-acute COVID-19 syndrome is strongly associated with specific cerebrospinal fluid and plasma mediators.
NATURE COMMUNICATIONS
(2022)
Article
Clinical Neurology
Pardis Zarifkar et al.
Summary: The risk of neurodegenerative and cerebrovascular, but not neuroimmune, disorders was increased among COVID-19 positive outpatients compared to COVID-negative outpatients. However, except for ischemic stroke, most neurological disorders were not more frequent after COVID-19 than after other respiratory infections.
FRONTIERS IN NEUROLOGY
(2022)
Article
Medicine, General & Internal
Sarah Wulf Hanson et al.
Summary: This study estimated the proportion and duration of Long COVID symptoms in individuals with symptomatic SARS-CoV-2 infection in 2020 and 2021. The results showed differences in the prevalence and duration of Long COVID symptoms across different age and gender groups.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2022)
Article
Immunology
Mathilde Bellon et al.
Summary: This study analyzed the cerebrospinal fluid features of 31 COVID-19 patients with neurological complications and found no SARS-CoV-2 RNA or intrathecal IgG synthesis, but observed signs of blood-brain barrier disruption. These results may help improve understanding of SARS-CoV-2 related neuropathogenesis.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Clinical Neurology
Jennifer A. Frontera et al.
Summary: This study found that 13.5% of COVID-19 patients developed new neurologic disorders, which were associated with increased risk of in-hospital mortality and decreased likelihood of discharge home.
Article
Chemistry, Multidisciplinary
Qingle Ma et al.
Summary: Engineering platelet-derived extracellular vesicles (PEVs) to load MCC950, an NLRP3-inflammasome inhibitor, for atherosclerosis-targeted therapy can significantly reduce plaque formation, lower local inflammation, and inhibit proliferation of macrophages and T cells at the plaque site compared with free drug administration. This strategy indicates the promising potential of PEVs for targeted drug delivery in atherosclerosis treatment.
JOURNAL OF CONTROLLED RELEASE
(2021)
Review
Clinical Neurology
Fangda Leng et al.
Summary: Microglial activation and neuroinflammation play important roles in Alzheimer's disease, affecting disease progression and pathologies. Current research focuses on the interplay between neuroinflammation and amyloid and tau pathologies, with a specific interest in modulating microglia as a therapeutic strategy for AD.
NATURE REVIEWS NEUROLOGY
(2021)
Article
Biochemistry & Molecular Biology
Carole H. Sudre et al.
Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.
Review
Neurosciences
Carole Escartin et al.
Summary: The article highlights the challenges and uncertainties surrounding reactive astrocytes, advocating for comprehensive research that includes assessment of multiple molecular and functional parameters, preferably in vivo, along with multivariate statistics and determination of impact on pathological hallmarks in relevant models.
NATURE NEUROSCIENCE
(2021)
Review
Cell & Tissue Engineering
Shay Herman et al.
Summary: Neurological disorders are characterized by cell degeneration and neural functional deficiencies in the central nervous system. MSC-derived EVs can be administered intranasally to effectively target the CNS and deliver cargo to modulate gene expression and protein functions. This therapy shows promise in treating neurological diseases by modulating immune responses, promoting neurogenesis, and protecting neurons.
Article
Oncology
Alice Bertocchi et al.
Summary: Bacteria from primary tumors can lead to bacterial dissemination from the intestine to the liver, disrupting the gut vascular barrier, boosting the formation of a premetastatic niche, and enhancing the recruitment of metastatic cells. High levels of PV-1, a marker of impaired gut vascular barrier, are associated with liver bacteria dissemination and metachronous distant metastases in colorectal cancer patients, making it a prognostic marker for distant recurrence and vascular impairment.
Article
Neurosciences
Philip Hasel et al.
Summary: This study investigated the transcriptome changes of mouse cortical astrocytes after an acute inflammatory stimulus, revealing rapid and drastic changes over time. By sequencing thousands of astrocytes at single-cell resolution, it was shown that inflammation causes a widespread response with distinct subtypes undergoing inflammatory transitions with defined transcriptomic profiles. Spatial transcriptomics and in situ hybridization were used to attribute specific inflammation-induced reactive astrocyte sub-states to certain brain regions.
NATURE NEUROSCIENCE
(2021)
Article
Engineering, Biomedical
Qingle Ma et al.
Summary: A targeted delivery platform based on PEVs loaded with BBR has been developed for RA treatment, showing promising results in reducing inflammation and joint damage in RA mice. This strategy has the potential to enhance the efficacy of RA treatment with limited side effects.
ADVANCED NANOBIOMED RESEARCH
(2021)
Article
Materials Science, Biomaterials
Qingle Ma et al.
Summary: A targeted delivery strategy based on PEVs for DEX delivery in acute pneumonia was developed to reduce side effects and improve therapeutic efficacy, shedding light on issues in DEX-based acute pneumonia therapy clinically.
BIOMATERIALS SCIENCE
(2021)
Review
Neurosciences
Christopher D. Link
Summary: Numerous studies have identified microbial sequences or epitopes in pathological and non-pathological human brain samples, but it is still uncertain whether these observations are artifactual or truly representative of brain contamination by microbes. While the evidence for the presence of microbes in diseased brains is strong, a convincing demonstration of resident microbes in the healthy human brain is still lacking. Dedicated animal model studies may be necessary to determine the existence of a brain microbiome.
NEUROSCIENCE INSIGHTS
(2021)
Review
Clinical Neurology
Imran Ahmad et al.
JOURNAL OF CLINICAL NEUROSCIENCE
(2020)
Article
Neurosciences
Naomi Habib et al.
NATURE NEUROSCIENCE
(2020)
Letter
Clinical Neurology
Nikolaus Deigendesch et al.
ACTA NEUROPATHOLOGICA
(2020)
Letter
Clinical Neurology
Bernhard Neumann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES
(2020)
Article
Immunology
Takahiro Masuda et al.
Review
Neurosciences
Hyuk Sung Kwon et al.
TRANSLATIONAL NEURODEGENERATION
(2020)
Review
Clinical Neurology
Kyle M. Blackburn et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
(2020)
Article
Materials Science, Multidisciplinary
Qingle Ma et al.
Review
Neurosciences
Sohair Geyer et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE
(2019)
Review
Immunology
Darshpreet Kaur et al.
INFLAMMOPHARMACOLOGY
(2019)
Article
Gastroenterology & Hepatology
Juliette Mouries et al.
JOURNAL OF HEPATOLOGY
(2019)
Review
Neurosciences
Thulani H. Palpagama et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE
(2019)
Review
Clinical Neurology
J. S. Bell et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
(2019)
Review
Clinical Neurology
Peter B. Crino
NATURE REVIEWS NEUROLOGY
(2016)
Article
Clinical Neurology
Danielle N. Doll et al.
Article
Multidisciplinary Sciences
Marc A. Sze et al.
Review
Neurosciences
Zhao Zhong Chong et al.
PROGRESS IN NEUROBIOLOGY
(2012)
Review
Clinical Neurology
Jeffrey J. Ekstrand
SEMINARS IN PEDIATRIC NEUROLOGY
(2012)
Review
Neurosciences
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE
(2010)
Review
Neurosciences
Monica M. Mariani et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
(2009)
Article
Cell Biology
H Björkbacka et al.
PHYSIOLOGICAL GENOMICS
(2004)
